Classifying ‘Drug-likeness' with Kernel-Based Learning Methods

Klaus-Robert Müller, Gunnar Rätsch,§ Sören Sonnenburg,* Sebastian Mika, Michael Grimm, and Nikolaus Heinrich
Fraunhofer FIRST, Kekulstrasse 7, 12489 Berlin, Germany, Computer Science, University of Potsdam, August-Bebel-Strasse 89, 14482 Potsdam, Germany, Friedrich Miescher Laboratory of the Max Planck Society, Spemannstrasse 39, 72076 Tbingen, Germany, idalab GmbH, Mohrenstrasse 63, 10117 Berlin, Germany, and Computational Chemistry, Schering AG, Mllerstrasse 178, 13342 Berlin, Germany
J. Chem. Inf. Model., 2005, 45 (2), pp 249–253
DOI: 10.1021/ci049737o
Publication Date (Web): February 8, 2005
Copyright © 2005 American Chemical Society

 Fraunhofer FIRST.

,

 University of Potsdam.

,
§

 Friedrich Miescher Laboratory of the Max Planck Society.

,
*

 Corresponding author e-mail:  soeren.sonnenburg@first.fraunhofer.de.

,

 idalab GmbH.

,

 Schering AG.

Abstract

In this article we report about a successful application of modern machine learning technology, namely Support Vector Machines, to the problem of assessing the ‘drug-likeness' of a chemical from a given set of descriptors of the substance. We were able to drastically improve the recent result by Byvatov et al. (2003) on this task and achieved an error rate of about 7% on unseen compounds using Support Vector Machines. We see a very high potential of such machine learning techniques for a variety of computational chemistry problems that occur in the drug discovery and drug design process.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

History

  • Published In Issue March 28, 2005
  • Received August 24, 2004

Recommend & Share

Related Content

Other ACS content by these authors: